Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 1291 AL 1305

Polyphenolic Antioxidants and Neuronal Regeneration

Ataie A, Shadifar M, Ataee R.

Basic Clin Neurosci. 2016 Apr;7(2):81-90. doi: 10.15412/J.BCN.03070201.

Molecular and genetic inflammation networks in major human diseases

Zhao Y, Forst CV, Sayegh CE, Wang IM, Yang X, Zhang B.

Mol Biosyst. 2016 Jul 19;12(8):2318-41. doi: 10.1039/c6mb00240d.

The use of MALDI-MSI in the investigation of psychiatric and neurodegenerative disorders: A review

Schubert KO, Weiland F, Baune BT, Hoffmann P.

Proteomics. 2016 Jun;16(11-12):1747-58. doi: 10.1002/pmic.201500460. Epub 2016 May 17.

Recent Advances in Nucleic Acid-Based Delivery: From Bench to Clinical Trials in Genetic Diseases

Oliveira C, Ribeiro AJ, Veiga F, Silveira I.

J Biomed Nanotechnol. 2016 May;12(5):841-62. doi: 10.1166/jbn.2016.2245.

The Evolution of REM Sleep Behavior Disorder in Early Parkinson Disease

Sixel-Döring F, Zimmermann J, Wegener A, Mollenhauer B, Trenkwalder C.

Sleep. 2016 Sep 1;39(9):1737-42. doi: 10.5665/sleep.6102.

The NFE2L2 rs35652124 polymorphism and the risk of Parkinson's disease: a systematic review and meta-analysis

Zhu M, Zhou T, Zu G, Liang Z.

Neuroreport. 2016 Aug 17;27(12):901-5. doi: 10.1097/WNR.0000000000000627.

Oestrogens and Progestagens: Synthesis and Action in the Brain

Rossetti MF, Cambiasso MJ, Holschbach MA, Cabrera R.

J Neuroendocrinol. 2016 Jul;28(7). doi: 10.1111/jne.12402.

The Wolff-Parkinson-White Syndrome: A Test Bed for the Assessment of Myocardial Dyssynchrony?

Maréchaux S.

Circ Cardiovasc Imaging. 2016 Jun;9(6):e005112. doi: 10.1161/CIRCIMAGING.116.005112.

Circadian disruption: New clinical perspective of disease pathology and basis for chronotherapeutic intervention

Smolensky MH, Hermida RC, Reinberg A, Sackett-Lundeen L, Portaluppi F.

Chronobiol Int. 2016;33(8):1101-19. doi: 10.1080/07420528.2016.1184678. Epub 2016 Jun 16.

N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line Data

Monti DA, Zabrecky G, Kremens D, Liang TW, Wintering NA, Cai J, Wei X, Bazzan AJ, Zhong L, Bowen B, Intenzo CM, Iacovitti L, Newberg AB.

PLoS One. 2016 Jun 16;11(6):e0157602. doi: 10.1371/journal.pone.0157602. eCollection 2016.

The Evolution of Genetics: Alzheimer's and Parkinson's Diseases

Singleton A, Hardy J.

Neuron. 2016 Jun 15;90(6):1154-1163. doi: 10.1016/j.neuron.2016.05.040.

Melanin and neuromelanin binding of drugs and chemicals: toxicological implications

Karlsson O, Lindquist NG.

Arch Toxicol. 2016 Aug;90(8):1883-91. doi: 10.1007/s00204-016-1757-0. Epub 2016 Jun 16.

A review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer's disease and Parkinson's disease

McGhee DJ, Ritchie CW, Zajicek JP, Counsell CE.

BMC Neurol. 2016 Jun 16;16:92. doi: 10.1186/s12883-016-0606-3.

Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management

Chang A, Fox SH.

Drugs. 2016 Jul;76(11):1093-118. doi: 10.1007/s40265-016-0600-5.

Targeting delivery in Parkinson's disease

Newland B, Dunnett SB, Dowd E.

Drug Discov Today. 2016 Aug;21(8):1313-20. doi: 10.1016/j.drudis.2016.06.003. Epub 2016 Jun 14.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias